Medical technology for the bedside · London

The new instruments of medicine.

Innovatr builds the instruments clinical teams have been missing. Engineered in London, shaped at the bedside. From the founders of The Simulator Company, the global leader in ECMO simulation and advanced circulatory therapy.

  • Engineered in London
  • From the founders of The Simulator Company
  • Global leader in ECMO simulation
  • Simulators in use around the world
  • First release: Perfusion-Pilot OS
  • Translated into 102 languages

Why we exist

Extraordinary work, done with ordinary tools.

Clinicians have spent years working without the tools and therapy support their work demands, and that gap does not stay in the room. It reaches the patient.

Innovatr exists to close it. We work across medical AI, medical devices and medical robotics. Three disciplines, one purpose: the clinician at the bedside, and the person in their care. We begin where we know the ground best, in extracorporeal circulation, and we announce products only when they are real.

Evidence within reach.

Too much of what we know sits locked inside six-figure hardware or behind a paywall. Guidance and the numbers that matter belong within reach of every clinician, not only in the best-funded theatres.

Less to carry, mentally.

The workforce is shrinking, ageing and increasingly stretched across roles. Technology should take the weight off the people doing the work, not add to it.

Nothing lost at handover.

Care that carries forward across shifts, through multi-day runs and into the record, instead of dissolving into scattered notes and institutional memory.

We are deliberate about what we claim for any single product. Our first release is an educational reference tool, not a medical device. But our ethos, at its core, is simpler than any product we make. We build for the clinician at the console, and the patient at the end of the line.

Our focus

One product. Every shift.

Everything Innovatr makes serves the clinician at the point of care. We build one thing at a time, and we build it properly, starting with the software a perfusionist opens every shift.

01 / First release

Perfusion-Pilot OS

CPB, ECMO and NRP reference for the extracorporeal team: 39 cited calculators, therapy-specific checklists, cases, rounds and recertification in one fast, offline companion. In 102 languages.

Early access on iPhone and iPad. Android in preparation
Explore the product

More is on the bench. We announce products when they’re real.

First release

Perfusion-Pilot OS

CPB, ECMO and NRP reference for the extracorporeal team.

The app a perfusionist opens at the start and end of every shift. CPB, ECMO, NRP, VAD, cell salvage and IABP in one fast, offline, maintained companion.

  • 39 verified calculators

    Pump flow, DO₂i, prime, cardioplegia, ACT and 35 more, each showing its equation and switching units.

  • Case Command Centre

    One workspace per case: tap-to-log key values, smart tasks, a timeline and a quality snapshot.

  • ECMO Daily Rounds

    Multi-day run management with a complication watchlist that carries the case forward.

  • Recertification Logbook

    Procedures, roles and totals against your own annual target. The career record that builds itself as you work.

PerfusionPilot OS is a reference and education tool. It is not a medical device and does not diagnose, treat or monitor. Clinical decisions rest with the treating team.

Calculators: equations, units and sources Trends: charts of logged case values Toolkit: pump flow, DO₂i, prime and ACT

Cited calculators

How we build

Principles that don’t waver.

Evidence first.

Every clinical statement in our software carries its citation. If we can’t source it, we don’t ship it.

Built beside clinicians.

Our tools are shaped with the people who use them, the same way our simulators were built with the teams they train.

Privacy by design.

Work is logged on the device first. No name, MRN or DOB ever leaves it, and this website sets no cookies and runs no trackers.

Honest positioning.

PerfusionPilot is an educational reference tool, not a medical device, and our marketing says so everywhere our product does.

First we built the machines that trained the clinicians. Now we build the machines that work beside them.

The story

Born from the world of ECMO simulation.

Innovatr was founded in London by Sagar Haval and Babita Haval, who also founded The Simulator Company, the global leader in ECMO simulation and advanced circulatory therapy, whose simulators train clinical teams around the world.

The Simulator Company began as research in 2017 and was established in London in October 2019. Its E-SIM range launched globally in 2022, and its award-winning simulators, from E-SIM Pro to LVAD-SIM, now train hospitals, universities and device manufacturers globally.

Years spent building high-fidelity simulators for extracorporeal life support taught us exactly where technology fails the people who use it, and where it could do so much more. Innovatr is the next chapter: the same obsession with clinical realism, now aimed directly at the bedside itself. The goal is simple: to give clinical teams the instruments their work has always deserved, starting with the field we helped shape through training.

SH
Sagar Haval
Co-founder & CEO, Innovatr and The Simulator Company
BH
Babita Haval
Co-founder, Innovatr and The Simulator Company
  1. 2017

    Research begins on the first E-SIM simulators.

  2. 2019

    The Simulator Company is established in London.

  3. 2022

    Global launch at an international conference in London.

  4. 2023

    Innovatr is incorporated in London as the next chapter.

  5. 2026

    Innovatr launches Perfusion-Pilot OS to the extracorporeal field.

Contact

Let’s build the future of medicine.

Clinical partnerships, institutional pilots, press, or just tell us what to build next.

Registered office

Innovatr Limited
7 Bell Yard, London WC2A 2JR
United Kingdom

Response

Every message is read by the founders. We reply to genuine enquiries, usually within a few working days.

Unsolicited ideas and suggestions are received under our idea submission policy. Please don’t send anything you consider confidential.